Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  Affymetrix, Inc.    AFFX   US00826T1088

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/21/2015 07/22/2015 07/23/2015 07/24/2015 07/27/2015 Date
11.19(c) 11.38(c) 11.21(c) 11.05(c) 10.92(c) Last
386 268 717 910 480 888 531 694 572 950 Volume
0.00% +1.70% -1.49% -1.43% -1.18% Change
More quotes
Financials ($)
Sales 2015 361 M
EBIT 2015 35,1 M
Net income 2015 16,0 M
Debt 2015 39,6 M
Yield 2015 -
Sales 2016 377 M
EBIT 2016 39,2 M
Net income 2016 24,0 M
Debt 2016 52,1 M
Yield 2016 -
PER 2015 78,00
PER 2016 53,53
EV / Sales 2015 2,44x
EV / Sales 2016 2,37x
Capitalization 843 M
More Financials
Company
Affymetrix, Inc. provides life science and molecular diagnostic products that enable parallel analysis of biological systems at the gene, protein and cell level.It develops, manufactures and sells products and services for genetic analysis to the genomic research centers, academic institutions,... 
More about the company
Surperformance© ratings of Affymetrix, Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on AFFYMETRIX, INC.
07/23 AFFYMETRIX : Cytox and Affymetrix form strategic partnership to develop and comm..
07/20 AFFYMETRIX : Cytox and Affymetrix : Form Strategic Partnership to Develop and Co..
07/20 AFFYMETRIX : Cytox and Affymetrix Form Strategic Partnership to Develop and Comm..
07/16 AFFYMETRIX : Presolicitation Notice - Annual Preventative Maintenance Agreement ..
07/16 AFFYMETRIX : Schedules Date to Report Second Quarter 2015 Operating Results
07/15 AFFYMETRIX : Genotyping Begins on NIDA's Biorepository of Over 50,000 Samples - ..
07/09 AFFYMETRIX : Sets Date to Report Second Quarter 2015 Operating Results
07/07 AFFYMETRIX : Genotyping Begins on NIDA’s Biorepository of Over 50,000 Samp..
More news
Sector news : Bio Diagnostics & Testing
07/27 ALNYLAM PHARMACEUTICALS : Initiates Phase 1/2 Clinical Trial for ALN-AAT, an Inv..
07/27 ISIS PHARMACEUTICALS : Reports Data from ISIS-TTR Rx in patients with Transthyre..
07/23 ANACOR PHARMACEUTICALS : to Report Second Quarter 2015 Financial Results on Augu..
More sector news : Bio Diagnostics & Testing
News from SeekingAlpha
07/23 Eli Lilly At The Start Of A Treatment For Alzheimer's Disease
07/21 PREMARKET BIOTECH DIGEST : Sanofi And Cholesterol, Novartis Misses, Alzheimer's ..
07/20 Affymetrix and Cytox team up to develop Alzheimer's test
07/11 INSIDERINSIGHTS.COM DAILY ROUND UP 7 : Coty, abcp, layn, isns
06/01 Insider Wisdom And The New Medicine


Comments 
Advertisement
Chart AFFYMETRIX, INC.
Duration : Period :
Affymetrix, Inc. Technical Analysis Chart | AFFX | US00826T1088 | 4-Traders
Full-screen chart
Technical analysis trends AFFYMETRIX, INC.
Short TermMid-TermLong Term
TrendsNeutralBearishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions